Johnson & Johnson (FRA:JNJ)
156.04
+2.20 (1.43%)
At close: Sep 30, 2025
Johnson & Johnson Revenue
Johnson & Johnson had revenue of $23.74B USD in the quarter ending June 29, 2025, with 5.77% growth. This brings the company's revenue in the last twelve months to $90.63B, up 4.68% year-over-year. In the year 2024, Johnson & Johnson had annual revenue of $88.82B with 4.30% growth.
Revenue (ttm)
$90.63B
Revenue Growth
+4.68%
P/S Ratio
4.92
Revenue / Employee
$656.24K
Employees
138,100
Market Cap
380.60B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 29, 2024 | 88.82B | 3.66B | 4.30% |
Dec 31, 2023 | 85.16B | 5.17B | 6.46% |
Jan 1, 2023 | 79.99B | 1.25B | 1.59% |
Jan 2, 2022 | 78.74B | -3.84B | -4.65% |
Jan 3, 2021 | 82.58B | 525.00M | 0.64% |
Dec 29, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jan 1, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jan 3, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
SAP SE | 35.89B |
Siemens Aktiengesellschaft | 78.30B |
Deutsche Telekom AG | 120.55B |
Allianz SE | 109.02B |
Rheinmetall AG | 10.67B |
Siemens Energy AG | 38.39B |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.33B |
Deutsche Bank Aktiengesellschaft | 30.07B |
Johnson & Johnson News
- 1 day ago - U.S. FDA approves TREMFYA® (guselkumab) for the treatment of pediatric plaque psoriasis and active psoriatic arthritis, marking a first and only approval for an IL-23 inhibitor - PRNewsWire
- 3 days ago - Best Dividend Aristocrats For October 2025 - Seeking Alpha
- 6 days ago - Johnson & Johnson (JNJ) Presents at Bernstein 2nd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 7 days ago - The White House Kicks Tylenol Into Crisis Mode Again. Will Its PR Playbook Work This Time? - Adweek
- 7 days ago - Johnson & Johnson (JNJ) Withdraws LINX System from Non-U.S. Markets - GuruFocus
- 7 days ago - Johnson & Johnson (JNJ) Rebounds with 0.7% Increase in Early Trading - GuruFocus
- 7 days ago - Johnson & Johnson (JNJ) Gains Following Stock Upgrade - GuruFocus
- 7 days ago - Guggenheim Upgrades Johnson & Johnson (JNJ) with Raised Price Target | JNJ Stock News - GuruFocus